Indeed, twenty years ago Guerin and colleagues described a correlation linking high c-Myb levels with several good prognostic features, such as low tumor grade, ER+ status, and an anti-correlation to poor outcome inflammatory breast carcinomas [18]. The gene discussed is MYB; the disease is breast carcinoma.